Trasylol (Aprotinin) is a serine protease inhibitor obtained from bovine (cow) lung or pancreas and is used to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass (CPB) in the course of coronary artery bypass graft surgery (CABG).
Recently studies have linked Trasylol to an increased risk of kidney damage, heart attacks, and strokes.
If you or a loved one have experienced complications after cardiopulmonary bypass (CPB) or coronary artery bypass graft surgery (CABG), you should contact your medical providers to determine if Trasylol was used during the procedure. If Trasylol was used and you or a loved experienced complications you may be entitled to compensation. To learn more about your legal rights or to inquire about a Trasylol lawsuit, contact the Trasylol lawyers of Ennis & Ennis today.
The United States Food and Drug Administration (FDA) issued a Trasylol public health advisory on February 8, 2006.
The advisory states that the FDA is conducting a safety evaluation for Trasylol to assess the drug’s risks. Doctors are warned to carefully weigh the potential benefits and risks of Trasylol before administering the drug to patients. Patients who take Trasylol should be monitored for toxicity of the kidneys, heart, and central nervous system. Adverse events must be promptly reported to Bayer or the FDA Medwatch program.
Ennis & Ennis, P.A. is representing individuals that have been harmed as a result of Trasylol side effects. If you or a loved one have suffered as a result of Trasylol side effects such as kidney failure, heart attack, or stroke you may be entitled to compensation. For more information about a Trasylol lawsuit, a possible Trasylol recall, or for questions regarding Trasylol class action lawsuits click for a free, confidential case evaluation. Our on-staff nurse and attorneys are standing by to answer any questions you may have regarding Trasylol side effects, a possible Trasylol class action lawsuit, or any other type of Trasylol litigation. |
08/31/2009 - A man and woman have filed a suit against Bayer, alleging they were not warned of possible side effects in a drug used to control bleeding in coronary artery bypass grafting. More>>>
05/12/2009 - It is a a major breakthrough in combating fraud and corruption: At today's annual general shareholders meeting of Germanys Bayer AG, a former pharmaceutical employee intends to unveil severe corruption practices within BAYER. More>>>
01/09/2009- A Calgary law firm has launched a class-action suit against pharmaceutical giant Bayer Inc. for its drug Trasylol, alleging it causes kidney failure, stroke and other serious health problems. More>>>
01/08/2009- For as long as large pharmaceutical drug companies have been around illegal kickbacks have been awarded to serve as an incentive for doctors to use specific drugs. These kickbacks have attributed to numerous cases where a patient has suffered due to their doctor recommending a drug that they received a kickback for. More>>>
News Archive >>>
|